top of page

Search Results

Search results for "opioid signaling"

Results found for "opioid signaling"

  • Dr. GPCR University registration is now open! Secure your spot now!

    Calebiro, Michael Decker, et al. for their study on Design, Synthesis, and Characterization of New δ Opioid Let’s dive into the Classified GPCR News from July 22 to 28, 2024 GPCR Activation and Signaling Activating Inverse Regulation of C-C Chemokine Receptor 3 Oligomerization by Downstream Proteins Indicates Biased Signal for diabetes treatment GPCRs in Neuroscience Astrocytes control quiescent NSC reactivation via GPCR signaling-mediated targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation Signaling

  • Integrative model of the FSH receptor reveals the structural role of the flexible hinge region

    How this HR is involved in hormone binding and signal transduction is still an open question. The models are expected to allow for testable hypotheses about signal transduction and drug development

  • Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...

    Ca2+ (Ca2+o ) via a dimeric extracellular Venus flytrap (VFT) unit that activates G protein-dependent signaling corresponding to heterozygous familial hypocalciuric hypercalcemia type-1 (FHH-1), supported maximal signaling In contrast, a single WT HH bundle was insufficient for maximal signaling and there was no functional Finally, we observed that the Ca2+o -stimulated CaSR operated exclusively via signaling in-trans and not via combined in-trans and in-cis signaling.

  • 📰 GPCR Weekly News, March 27 to April 4, 2023

    GPCR Symposium on GPCR Activation and Signaling held on May 19th, 2023. Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia. Gαi-derived peptide binds the µ-opioid receptor. Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2.

  • 📰 GPCR Weekly News, May 22 to 28, 2023

    GPCR Activation and Signaling The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation Multiple Subthreshold GPCR Signals Combined by the G-Proteins Gαq and Gαs Activate the Caenorhabditis The intertwining roles of caveolin, oxytocin receptor, and the associated signalling pathways in prostate Your body naturally produces opioids without causing addiction or overdose – studying how this process (June 28 - 30, 2023) FREE 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July

  • Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to...

    October 2022 Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inverse agonism "Dimerization of beta 2-adrenergic receptor (β2-AR) has been observed across various physiologies. However, the function of dimeric β2-AR is still elusive. Here, we revealed that dimerization of β2-AR is responsible for the constitutive activity of β2-AR generating inverse agonism. Using a co-immunoimmobilization assay, we found that transient β2-AR dimers exist in a resting state, and the dimer was disrupted by the inverse agonists. A Gαs preferentially interacts with dimeric β2-AR, but not monomeric β2-AR, in a resting state, resulting in the production of a resting cAMP level. The formation of β2-AR dimers requires cholesterol on the plasma membrane. The cholesterol did not interfere with the agonist-induced activation of monomeric β2-AR, unlike the inverse agonists, implying that the cholesterol is a specific factor regulating the dimerization of β2-AR. Our model not only shows the function of dimeric β2-AR but also provides a molecular insight into the mechanism of the inverse agonism of β2-AR." Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024

    in cardiac and endothelial cell function Protein Biochemist/Structural Biologist GPCR Activation and Signaling Beyond the classic GPCR: unraveling the role of GPR155 role in cholesterol sensing and signaling High-affinity of the M1 Receptor The cell adhesion molecule CD44 acts as a modulator of 5-HT7 receptor functions Signal profiles and spatial regulation of β-arrestin recruitment through Gβ5 and GRK3 at the μ-opioid receptor GPCR Binders, Drugs, and more Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    The reagents are compatible with HTRF readers  and validated in GLP1R  and Mu opioid receptor (MOR)   pHSense™ is the latest addition to Revvity’s GPCR reagent portfolio , which supports every stage of the signaling

  • TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms

    August 2022 "The calcium-permeable cation channel TRPM3 can be activated by heat and the endogenous steroid pregnenolone sulfate. TRPM3's best understood function is its role as a peripheral noxious heat sensor in mice. However, the channel is expressed in various tissues and cell types including neurons as well as glial and epithelial cells. TRPM3 expression patterns differ between species and change during development. Furthermore, a plethora of TRPM3 variants that result from alternative splicing have been identified and the majority of these isoforms are yet to be characterized. Moreover, the mechanisms underlying regulation of TRPM3 are largely unexplored. In addition, a micro-RNA gene (miR-204) is located within the TRPM3 gene. This complexity makes it difficult to obtain a clear picture of TRPM3 characteristics. However, a clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic marker and therapeutic target. Therefore, the newest data related to TRPM3 have to be discussed and to be put in context as soon as possible to be up-to-date and to accelerate the translation from bench to bedside. The aim of this review is to highlight recent results and developments with particular focus on findings from studies involving ocular tissues and cells or peripheral neurons of rodents and humans." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    A Final Aha Moment: Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids

  • VAMP2: a crucial player in the delivery of MOR to the synapse

    Some studies have suggested that VAMP2 may be involved in regulating dopamine D2 receptor signaling by In addition, VAMP2 can interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid with different fusion proteins and also this different molecular codes will be modulated by different opioids Conformational specificity of opioid receptors is determined by subcellular location irrespective of

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    Terence Hébert , et al. for their work on Understanding the impact of nuclear-localized GPCRs on cellular signaling Postdoctoral Position Postdoctoral research position Senior or Lead Researcher   GPCR Activation and Signaling GPCRs on cellular signalling GRK2 is critical for the cleavage of the porcine embryo by regulating HSP90 Biosensors Reveals Functional Differences among Receptor Paralogs GPCRs in Neuroscience Opposing GPCR signaling Receptor 2 with a Versatile Intracellular Allosteric Probe Selective optogenetic inhibition of Gαq or Gαi signaling

  • 📰 GPCR Weekly News, June 10 to 16, 2024

    Teye Azietaku for his contributor article on Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling GPCR Activation and Signaling Emerging modes of regulation of neuromodulatory G protein-coupled receptors mGluR2/3 control synaptic glutamate time course at hippocampal CA1 synapses Regulator of G protein signaling behavioral reward, and susceptibility to relapse Alcohol consumption does not impact delta and kappa opioid GPCR Events, Meetings, and Webinars June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. GPCR Activation and Signaling How can we improve the measurement of receptor signaling bias? Phosphorylation barcodes direct biased chemokine signaling at CXCR3. Subcellular location defines GPCR signal transduction. Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development The pathway of opioid

  • What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024

    /Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry GPCR Activation and Signaling 3 ion channel Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling physiological implications Sphingosine-1-phosphate activates LRRC8 volume-regulated anion channels through Gβγ signalling Species GPCRs in Neuroscience Role of the GRK2/3 N-terminus in discriminating the endocytic effects of opioid Modelling and simulation of membrane proteins in a nutshell Ciliary length variations impact cilia-mediated signaling

  • Search for safer pain relief advances with new engineered compounds

    November 2021 "Chronic use of most opioids causes tolerance; the new compounds avoid this and other unwanted new pain-relieving compounds that, like morphine and other drugs, provide relief via activation of opioid receptors, but without inducing many dangerous and unwanted side-effects that have driven opioid-related

  • Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!

    Mikel Garcia-Marcos for their excellent work on Protocol to investigate G protein-coupled receptor signaling Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position GPCR Activation and Signaling pathways in GPCR-mediated activation of Ca2+ mobilization in HEK293 cells Activation of polycystin-1 signaling via ABCB1 in keratinocytes GPCRs in Neuroscience Ventral tegmental area amylin / calcitonin receptor signaling recognition Structural basis of psychedelic LSD recognition at dopamine D1 receptor Structural basis of μ-opioid

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    Robert Lefkowitz for their work on GPCRs: from radioligand binding to cellular signaling Dr. Next week, on March 15th, we are hosting a symposium on GPCR activation and signaling. Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury GPCRs in of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach Opioid pathway Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    GPCR Activation and Signaling Distinct beta-arrestin coupling and intracellular trafficking of metabotropic receptor homo- and heterodimers Structural basis of G protein-Coupled receptor CMKLR1 activation and signaling Binders, Drugs, and more Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid in alcohol use disorder GPCRs in Oncology and Immunology Regulator of G protein signaling protein 6 the A2A adenosine receptor Reviews, GPCRs, and more Structure, function and drug discovery of GPCR signaling

  • Exploring the Breakthroughs in GPCR Research

    , Jana Selent, et al. for their research on the Relevance of GPCR dynamics for receptor activation, signalling Let’s dive into the Classified GPCR News from July 8th to 14th, 2024 GPCR Activation and Signaling GPR116 short guide to heterotrimeric G protein activity biosensors Descriptive molecular pharmacology of the δ opioid activated by ACP (adipokinetic hormone/corazonin-related peptide) GPCRs in Oncology and Immunology S1P Signaling Metabolic Disease Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling

  • 📰 GPCR Weekly News, October 9 to 15, 2023

    Mechanical Activation: GAIN Domain Unfolding and Dissociation in Adhesion GPCRs GPCR Activation and Signaling fungus GPCR Binders, Drugs, and more Development of Photoswitchable Tethered Ligands that Target the µ-Opioid Neuroscience The Drosophila blood-brain barrier regulates sleep via Moody G protein-coupled receptor signaling

  • 📰 GPCR Weekly News, July 24 to July 30, 2023

    GPCR Activation and Signaling Endosome positioning coordinates spatially selective GPCR signaling. Development of a V5-tag-directed nanobody and its implementation as an intracellular biosensor of GPCR signalling Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat GPCRs in Neuroscience Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex

  • 📰 GPCR Weekly News, January 29 to February 4, 2024

    GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. GPCR signaling bias: an emerging framework for opioid drug development Structural and functional insight pathway The non-nutritive sweetener sucralose increases β-arrestin signaling at the constitutively active orphan G protein-coupled receptor GPR52 Endosome positioning coordinates spatially selective GPCR signaling GRK5 promoted renal fibrosis via HDAC5/Smad3 signaling pathway Non-canonical G protein signaling GPCR

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    obesity Norton Cheng, JoAnn Trejo, et al. for their research on Ubiquitin-driven GPCR Inflammatory Signaling Variable CGRP family peptide signaling durations and the structural determinants thereof Ubiquitin-driven G Protein-Coupled Receptor Inflammatory Signaling at the Endosome GPCR Binders, Drugs, and more Discovery GPCRs Industry News Introducing Big Sky BacMam Chemical tool illuminates pathways used by dopamine, opioids and other neuronal signals GPCR Events, Meetings, and Webinars May 13 - 17, 2024 | 20th Annual PEGS

  • 📰 GPCR Weekly News, April 15 to 21, 2024

    Let’s dive into the Classified GPCR News from April 15th to 21st, 2024 GPCR Activation and Signaling Beneath the surface: endosomal GPCR signaling The M3 muscarinic acetylcholine receptor can signal through Drugs, and more Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid induced pluripotent stem cell-derived nociceptive-like neurons Characterization of myoinhibitory peptide signaling 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling

  • 📰 GPCR Weekly News, May 13 to 19, 2024

    contributor article on Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling , et al., for their study on Constitutive internalisation of EP2 differentially regulates G protein signalling GPCR Activation and Signaling Constitutive internalisation of EP2 differentially regulates G protein signalling ArreSTick motif controls β-arrestin-binding stability and extends phosphorylation-dependent scope of angiotensin receptor pharmacology Structural and dynamic insights into the activation of the μ-opioid

  • 📰 GPCR Weekly News, July 17 to July 23, 2023

    Antony Boucard's research on "Biased Signaling is Structurally Encoded As An Autoproteolysis Event in Adhesion GPCRs Biased Signaling is Structurally Encoded As An Autoproteolysis Event in Adhesion G Protein-Coupled GPCR Activation and Signaling Atypical Chemokine Receptor 3 'Senses' CXC Chemokine Receptor 4 Activation GPCRs in Neuroscience Mu-opioid receptor selective superagonists produce prolonged respiratory depression Olanzapine manipulates neuroactive signals and may onset metabolic disturbances.

  • 📰 GPCR Weekly News - January 9 to 15, 2023

    GPCR Activation and Signaling New simulation insights on the structural transition mechanism of Bovine GPCR Binders, Drugs, and more Modelling altered signalling of G-protein coupled receptors in inflamed Cryo-EM structures of orphan GPR21 signaling complexes. The molecular associations in clathrin-coated pit regulate β-arrestin-mediated MAPK signaling downstream of μ-opioid receptor.

  • 📰 GPCR Weekly News, July 31 to August 6, 2023

    GPCRs Functional partnerships between GPI-anchored proteins and adhesion GPCRs GPCR Activation and Signaling biased intracellular agonist The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction The relaxin receptor RXFP1 signals through a mechanism of autoinhibition To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory

  • 📰 GPCR Weekly News, April 10 to 16, 2023

    GPCR Symposium on GPCR Activation and Signaling on May 19th, 2023. Adhesion GPCRs Downstream signaling of the disease associated mutations on GPR56/ADGRG1. GPCR Activation and Signaling Ligand-dependent intracellular trafficking of the G protein-coupled P2Y6 Computational insights into ligand-induced G protein and β-arrestin signaling of the dopamine D1 receptor In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies

bottom of page